Holdings of Fidelity Advisor Health Care Fund
Fidelity Advisor Series VII · Original filing · Compare with another fund · Report an error
- Net assets
- 3.1B $ including 3B $ in equities, 96.5 %
- Positions
- 99 in 9 countries
- Top ten
- 40.5 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 208,000 | 239M $ | 7.66 % |
| 2 | Danaher Corp | 1,080,000 | 210.6M $ | 6.75 % |
| 3 | Thermo Fisher Scientific Inc | 342,500 | 196.7M $ | 6.31 % |
| 4 | UnitedHealth Group Inc | 314,000 | 130.1M $ | 4.17 % |
| 5 | Johnson & Johnson | 460,000 | 117.9M $ | 3.78 % |
| 6 | AbbVie Inc | 450,000 | 112.9M $ | 3.62 % |
| 7 | Argenx SE | 76,500 | 65.3M $ | 2.09 % |
| 8 | Merck & Co Inc | 500,000 | 65.1M $ | 2.09 % |
| 9 | West Pharmaceutical Services Inc | 188,400 | 64.2M $ | 2.06 % |
| 10 | Ascendis Pharma A/S | 250,000 | 61M $ | 1.95 % |
| 11 | ALNYLAM PHARMACEUTICALS INC | 270,000 | 55.5M $ | 1.78 % |
| 12 | Agilent Technologies Inc | 395,000 | 54.7M $ | 1.75 % |
| 13 | VIATRIS INC | 2,960,000 | 52M $ | 1.67 % |
| 14 | NATERA INC | 192,290 | 51.5M $ | 1.65 % |
| 15 | GUARDANT HEALTH INC | 285,000 | 46.2M $ | 1.48 % |
| 16 | 10X Genomics Inc | 954,913 | 45.1M $ | 1.45 % |
| 17 | REVOLUTION MEDICINES INC | 240,300 | 45.1M $ | 1.44 % |
| 18 | Waters Corp | 118,000 | 44.5M $ | 1.43 % |
| 19 | ORUKA THERAPEUTICS INC | 428,000 | 41.3M $ | 1.32 % |
| 20 | UCB SA | 160,000 | 41.1M $ | 1.32 % |
| 21 | CVS Health Corp | 385,000 | 40.2M $ | 1.29 % |
| 22 | Gilead Sciences Inc | 300,000 | 39.1M $ | 1.25 % |
| 23 | Boston Scientific Corp | 820,000 | 38.3M $ | 1.23 % |
| 24 | Repligen Corp | 270,000 | 38.1M $ | 1.22 % |
| 25 | Enliven Therapeutics Inc | 670,000 | 36.7M $ | 1.18 % |
| 26 | COGENT BIOSCIENCES INC | 920,000 | 35.8M $ | 1.15 % |
| 27 | ROYALTY PHARMA PLC | 600,000 | 35.1M $ | 1.12 % |
| 28 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 460,000 | 34.2M $ | 1.10 % |
| 29 | VAXCYTE INC | 630,000 | 34.1M $ | 1.09 % |
| 30 | Spyre Therapeutics Inc | 340,000 | 33.4M $ | 1.07 % |
| 31 | JAZZ PHARMACEUTICALS PLC | 128,000 | 32.4M $ | 1.04 % |
| 32 | MODERNA INC | 585,000 | 32.1M $ | 1.03 % |
| 33 | Xenon Pharmaceuticals Inc | 468,000 | 29.3M $ | 0.94 % |
| 34 | Bruker Corp | 456,516 | 28.7M $ | 0.92 % |
| 35 | Illumina Inc | 138,000 | 28.3M $ | 0.91 % |
| 36 | Veracyte Inc | 600,000 | 27.8M $ | 0.89 % |
| 37 | LIFESTANCE HEALTH GROUP INC | 2,500,000 | 26.2M $ | 0.84 % |
| 38 | Praxis Precision Medicines Inc | 82,800 | 25.5M $ | 0.82 % |
| 39 | Sartorius Stedim Biotech | 125,000 | 24M $ | 0.77 % |
| 40 | KYMERA THERAPEUTICS INC | 228,000 | 23.6M $ | 0.76 % |
| 41 | Roivant Sciences Ltd | 640,000 | 21.7M $ | 0.70 % |
| 42 | MBX BIOSCIENCES INC | 328,000 | 21.6M $ | 0.69 % |
| 43 | PRIVIA HEALTH GROUP INC | 896,700 | 21.2M $ | 0.68 % |
| 44 | Insmed Inc | 208,000 | 20.5M $ | 0.66 % |
| 45 | Biogen Inc | 100,000 | 20.3M $ | 0.65 % |
| 46 | Relay Therapeutics Inc | 1,040,000 | 19.6M $ | 0.63 % |
| 47 | LEGEND BIOTECH CORP | 1,019,556 | 18.9M $ | 0.61 % |
| 48 | Cencora Inc | 60,000 | 18.7M $ | 0.60 % |
| 49 | Dianthus Therapeutics Inc | 163,257 | 17.5M $ | 0.56 % |
| 50 | Axsome Therapeutics Inc | 80,000 | 17.4M $ | 0.56 % |
| 51 | CG ONCOLOGY INC | 228,000 | 16.2M $ | 0.52 % |
| 52 | ZENAS BIOPHARMA INC | 500,000 | 15.7M $ | 0.50 % |
| 53 | Disc Medicine Inc | 200,000 | 15.4M $ | 0.49 % |
| 54 | Mineralys Therapeutics Inc | 600,000 | 15.3M $ | 0.49 % |
| 55 | BRIGHTSPRING HEALTH SERVICES INC | 250,000 | 14.9M $ | 0.48 % |
| 56 | CARIS LIFE SCIENCES INC | 933,749 | 14.6M $ | 0.47 % |
| 57 | BEONE MEDICINES LTD | 46,000 | 14.5M $ | 0.47 % |
| 58 | AMYLYX PHARMACEUTICALS INC | 715,000 | 14.5M $ | 0.47 % |
| 59 | VIRIDIAN THERAPEUTICS INC | 760,000 | 14.4M $ | 0.46 % |
| 60 | MIRUM PHARMACEUTICALS INC | 128,000 | 13.6M $ | 0.43 % |
| 61 | HeartFlow Inc | 520,000 | 13.1M $ | 0.42 % |
| 62 | Pharvaris NV | 400,000 | 13M $ | 0.42 % |
| 63 | ALUMIS INC | 460,000 | 13M $ | 0.42 % |
| 64 | Edwards Lifesciences Corp | 150,000 | 12.9M $ | 0.41 % |
| 65 | TWIST BIOSCIENCE CORP | 135,000 | 12.4M $ | 0.40 % |
| 66 | NEWAMSTERDAM PHARMA COMPANY NV | 420,000 | 11.7M $ | 0.37 % |
| 67 | TRAVERE THERAPEUTICS INC | 208,000 | 11.6M $ | 0.37 % |
| 68 | STRUCTURE THERAPEUTICS INC | 228,000 | 11M $ | 0.35 % |
| 69 | Kestra Medical Technologies Ltd | 471,200 | 10.8M $ | 0.34 % |
| 70 | ALIGNMENT HEALTHCARE INC | 708,000 | 10.5M $ | 0.34 % |
| 71 | Scholar Rock Holding Corp | 218,000 | 10.3M $ | 0.33 % |
| 72 | Stoke Therapeutics Inc | 330,000 | 9.5M $ | 0.31 % |
| 73 | Olema Pharmaceuticals Inc | 820,000 | 9.4M $ | 0.30 % |
| 74 | IRhythm Holdings Inc | 80,000 | 9.4M $ | 0.30 % |
| 75 | Viking Therapeutics Inc | 280,000 | 8.9M $ | 0.28 % |
| 76 | First Tracks Biotherapeutics Inc | 200,000 | 8.8M $ | 0.28 % |
| 77 | Immunocore Holdings PLC | 260,000 | 8.8M $ | 0.28 % |
| 78 | Trevi Therapeutics Inc | 480,000 | 8.8M $ | 0.28 % |
| 79 | DAMORA THERAPEUTICS INC | 280,000 | 8.1M $ | 0.26 % |
| 80 | CYTOMX THERAPEUTICS INC | 2,500,000 | 7.8M $ | 0.25 % |
| 81 | JADE BIOSCIENCES INC | 370,600 | 7.3M $ | 0.23 % |
| 82 | SHOULDER INNOVATIONS INC | 310,692 | 7.1M $ | 0.23 % |
| 83 | VERADERMICS INC | 60,000 | 6.3M $ | 0.20 % |
| 84 | Edgewise Therapeutics Inc | 143,000 | 5.5M $ | 0.18 % |
| 85 | Summit Therapeutics Inc | 400,000 | 5.2M $ | 0.17 % |
| 86 | Intuitive Surgical Inc | 14,000 | 4.9M $ | 0.16 % |
| 87 | TYRA BIOSCIENCES INC | 140,000 | 4.5M $ | 0.14 % |
| 88 | Contineum Therapeutics Inc | 280,000 | 4.3M $ | 0.14 % |
| 89 | Alamar Biosciences Inc | 160,000 | 4.1M $ | 0.13 % |
| 90 | Annexon Inc | 750,000 | 3.8M $ | 0.12 % |
| 91 | OUTSET MEDICAL INC | 800,000 | 3.7M $ | 0.12 % |
| 92 | GMR Solutions Inc | 282,226 | 3.6M $ | 0.12 % |
| 93 | Climb Bio Inc | 214,022 | 2.5M $ | 0.08 % |
| 94 | Upstream Bio Inc | 400,000 | 2.5M $ | 0.08 % |
| 95 | OCULAR THERAPEUTIX INC | 277,371 | 2.3M $ | 0.07 % |
| 96 | CRESCENT BIOPHARMA INC | 149,413 | 2.2M $ | 0.07 % |
| 97 | HEMAB THERAPEUTICS HOLDINGS INC | 33,000 | 1.6M $ | 0.05 % |
| 98 | Immunome Inc | 38,378 | 873.5K $ | 0.03 % |
| 99 | CYCLERION THERAPEUTICS INC | 1,500 | 5.2K $ | 0.00 % |
Sector breakdown
- Health care 58.3 %
- Unattributed 41.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 97.8 %
- EUR 2.2 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 88.8 %
- Netherlands 3.0 %
- Denmark 2.0 %
- Belgium 1.4 %
- Bermuda 1.1 %
- Ireland 1.1 %
- Canada 1.0 %
- Cayman Islands 0.9 %
- France 0.8 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 87 | 2.7B $ | 88.80 % |
| 2 | Netherlands | 3 | 90M $ | 2.99 % |
| 3 | Denmark | 1 | 61M $ | 2.03 % |
| 4 | Belgium | 1 | 41.1M $ | 1.37 % |
| 5 | Bermuda | 2 | 32.5M $ | 1.08 % |
| 6 | Ireland | 1 | 32.4M $ | 1.07 % |
| 7 | Canada | 1 | 29.3M $ | 0.97 % |
| 8 | Cayman Islands | 2 | 27M $ | 0.90 % |
| 9 | France | 1 | 24M $ | 0.80 % |
Cite this page
Titelia. "Holdings of Fidelity Advisor Health Care Fund". https://titelia.com/en/funds/S000005329